Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Westlake Chemical Partners LP is a chemicals business based in the US. Westlake Chemical Partners shares (WLKP) are listed on the NYSE and all prices are listed in US Dollars.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $26.47 |
|---|---|
| 52-week range | $21.61 - $27.40 |
| 50-day moving average | $24.96 |
| 200-day moving average | $25.94 |
| Wall St. target price | $28.14 |
| PE ratio | 13.6937 |
| Dividend yield | $1.886 (7.21%) |
| Earnings per share (TTM) | $1.93 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $26.47 from 2022-01-25
| 1 week (2022-01-19) | -1.05% |
|---|---|
| 1 month (2021-12-23) | 6.48% |
| 3 months (2021-10-26) | 2.28% |
| 6 months (2021-07-26) | -2.04% |
| 1 year (2021-01-26) | 11.50% |
|---|---|
| 2 years (2020-01-24) | 10.34% |
| 3 years (2019-01-25) | 16.61% |
| 5 years (2017-01-26) | 7.82% |
Valuing Westlake Chemical Partners stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Westlake Chemical Partners's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Westlake Chemical Partners's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 14x. In other words, Westlake Chemical Partners shares trade at around 14x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Westlake Chemical Partners's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.23. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Westlake Chemical Partners's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Westlake Chemical Partners's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $455.7 million.
The EBITDA is a measure of a Westlake Chemical Partners's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $1.1 billion |
|---|---|
| Operating margin TTM | 30.75% |
| Gross profit TTM | $378.9 million |
| Return on assets TTM | 15.84% |
| Return on equity TTM | 36.68% |
| Profit margin | 6.02% |
| Book value | $14.87 |
| Market capitalisation | $932.1 million |
TTM: trailing 12 months
Dividend payout ratio: 97.7% of net profits
Recently Westlake Chemical Partners has paid out, on average, around 97.7% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 7.21% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Westlake Chemical Partners shareholders could enjoy a 7.21% return on their shares, in the form of dividend payments. In Westlake Chemical Partners's case, that would currently equate to about $1.886 per share.
Westlake Chemical Partners's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Westlake Chemical Partners's most recent dividend payout was on 28 November 2021. The latest dividend was paid out to all shareholders who bought their shares by 9 November 2021 (the "ex-dividend date").
Over the last 12 months, Westlake Chemical Partners's shares have ranged in value from as little as $21.6149 up to $27.4. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Westlake Chemical Partners's is 1.149. This would suggest that Westlake Chemical Partners's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Westlake Chemical Partners LP acquires, develops, and operates ethylene production facilities and related assets in the United States. The company's ethylene production facilities primarily convert ethane into ethylene. It also sells ethylene co-products, including propylene, crude butadiene, pyrolysis gasoline, and hydrogen directly to third parties on a spot or contract basis. Westlake Chemical Partners GP LLC serves as the general partner of the company. The company was founded in 2014 and is headquartered in Houston, Texas. .
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
Everything we know about the Austin Gold IPO, plus information on how to buy in.
Everything we know about the VinFast IPO, plus information on how to buy in.
Everything we know about the Nexalin Technology IPO, plus information on how to buy in.